Anhui Anke Biotechnology (Group) Co., Ltd.

SZSE:300009 Stok Raporu

Piyasa değeri: CN¥15.3b

Anhui Anke Biotechnology (Group) Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 3/6

Anhui Anke Biotechnology (Group) has been growing earnings at an average annual rate of 32.7%, while the Biotechs industry saw earnings growing at 5.9% annually. Revenues have been growing at an average rate of 12.7% per year. Anhui Anke Biotechnology (Group)'s return on equity is 19.2%, and it has net margins of 28.3%.

Anahtar bilgiler

32.7%

Kazanç büyüme oranı

32.3%

EPS büyüme oranı

Biotechs Sektör Büyümesi11.3%
Gelir büyüme oranı12.7%
Özkaynak getirisi19.2%
Net Marj28.3%
Son Kazanç Güncellemesi30 Sep 2024

Yakın geçmiş performans güncellemeleri

Recent updates

Anhui Anke Biotechnology (Group) Co., Ltd.'s (SZSE:300009) Share Price Is Matching Sentiment Around Its Earnings

Sep 25
Anhui Anke Biotechnology (Group) Co., Ltd.'s (SZSE:300009) Share Price Is Matching Sentiment Around Its Earnings

Anhui Anke Biotechnology (Group) (SZSE:300009) Will Pay A Dividend Of CN¥0.25

May 23
Anhui Anke Biotechnology (Group) (SZSE:300009) Will Pay A Dividend Of CN¥0.25

Earnings Working Against Anhui Anke Biotechnology (Group) Co., Ltd.'s (SZSE:300009) Share Price

Mar 01
Earnings Working Against Anhui Anke Biotechnology (Group) Co., Ltd.'s (SZSE:300009) Share Price

Gelir ve Gider Dağılımı

Anhui Anke Biotechnology (Group) nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.


Kazanç ve Gelir Geçmişi

SZSE:300009 Gelir, gider ve kazançlar (CNY Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
30 Sep 242,7667831,086230
30 Jun 242,8778671,091235
31 Mar 242,9288791,078256
31 Dec 232,8668471,050255
30 Sep 232,646763954211
30 Jun 232,538755900207
31 Mar 232,392716861172
01 Jan 232,331703877166
30 Sep 222,328372862174
30 Jun 222,280307911168
31 Mar 222,217254941163
31 Dec 212,169207947167
30 Sep 212,096489944154
30 Jun 211,959441900134
31 Mar 211,871403867142
31 Dec 201,701359795129
30 Sep 201,702167781117
30 Jun 201,661140776119
31 Mar 201,681140785118
31 Dec 191,713124816120
30 Sep 191,607289799118
30 Jun 191,598280799112
31 Mar 191,52927078493
31 Dec 181,46226374487
30 Sep 181,38231765471
30 Jun 181,27629256499
31 Mar 181,17729050386
31 Dec 171,09627846570
30 Sep 171,00924945147
30 Jun 179412284660
31 Mar 178782094170
31 Dec 168491974020
30 Sep 167511693550
30 Jun 166961603180
31 Mar 166711483110
31 Dec 156361362980
30 Sep 156291372860
30 Jun 156091272840
31 Mar 155791152760
31 Dec 145421102570
30 Sep 145091072380
30 Jun 14472992210
31 Mar 14448942140
31 Dec 13430902080

Kaliteli Kazançlar: 300009 has high quality earnings.

Büyüyen Kar Marjı: 300009's current net profit margins (28.3%) are lower than last year (28.9%).


Serbest Nakit Akışı ve Kazanç Analizi


Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: 300009's earnings have grown significantly by 32.7% per year over the past 5 years.

Büyüme Hızlandırma: 300009's earnings growth over the past year (2.5%) is below its 5-year average (32.7% per year).

Kazançlar vs. Sektör: 300009 earnings growth over the past year (2.5%) exceeded the Biotechs industry 0.08%.


Özkaynak Getirisi

Yüksek ROE: 300009's Return on Equity (19.2%) is considered low.


Varlık Getirisi


Kullanılan Sermaye Getirisi


Geçmişte güçlü performans gösteren şirketleri keşfedin